Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) organized its second edition of the Neuro & Spine Onco conference that witnessed around 200 experts in neuro-oncology across the country discussing latest advancements in the management of brain and spine tumors.
Experts discussed strategies to make the management of cancers related to the central nervous system (CNS) more technically feasible, surgically safer, more effective and better accepted by patients.
Dr. (Prof.) Ishwar Chandra Premsagar, Chief of Neuro & Spine, Oncology Services, Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), and organizing chairman of the event said, “The conference aimed to raise awareness about brain and spine tumors, which can either originate from the brain tissue or metastasize from other body cancers. These vital organs are responsible for movement, speech, vision, and hearing. Tumors can lead to lifelong disabilities if not managed properly. Due to lack of screening tests for brain tumors, it’s important to recognise warning signs such as persistent headaches or seizures.”
The central theme of the conference was Cyberknife, a state-of-the-art radiation tool acquired by RGCIRC in 2023 for the treatment of not only neuro and spine cancers but also other body organ cancers. Since its introduction, RGCIRC has successfully completed over 200 Cyberknife procedures.
RGCIRC, Niti Bagh
